Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Roman, Stefanie
SRF388-201, NCT05359861: Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma	Active, not recruiting	2	134	US, RoW	SRF388, Atezolizumab, Tecentriq, Bevacizumab, Avastin, Placebo	Coherus Biosciences, Inc.	Hepatocellular Carcinoma	05/25	05/26
Yang, Jin-Mo
SRF388-201, NCT05359861: Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma	Active, not recruiting	2	134	US, RoW	SRF388, Atezolizumab, Tecentriq, Bevacizumab, Avastin, Placebo	Coherus Biosciences, Inc.	Hepatocellular Carcinoma	05/25	05/26
Yun, KyoungHee
SRF388-201, NCT05359861: Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma	Active, not recruiting	2	134	US, RoW	SRF388, Atezolizumab, Tecentriq, Bevacizumab, Avastin, Placebo	Coherus Biosciences, Inc.	Hepatocellular Carcinoma	05/25	05/26